Yoshiro Saito Selected Research

Stevens-Johnson Syndrome (Lyell's Syndrome)

1/2021	Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
1/2020	The Association Between Concurrence of Infection and the Onset of Severe Eruption or Liver Injury in Patients Using Antipyretic Analgesics: A Matched, Nested Case-Control Study.
1/2019	Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens-Johnson syndrome with severe ocular complications in Japanese individuals.
1/2019	The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.
1/2018	Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
12/2017	Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database.
1/2016	Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
1/2015	Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese.
8/2014	Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
4/2014	Independent strong association of HLA-A02:06 and HLA-B44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiro Saito Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 01/2002
19	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2021 - 11/2008
14	Drug-Related Side Effects and Adverse Reactions 04/2022 - 04/2005
14	Parkinson Disease (Parkinson's Disease) 03/2018 - 03/2007
11	Neutropenia 01/2014 - 01/2007
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2010
9	Insulin Resistance 02/2020 - 11/2010
8	Chemical and Drug Induced Liver Injury 10/2022 - 01/2012
8	Necrosis 01/2020 - 06/2006
7	Neuroblastoma 10/2018 - 02/2004
6	Hypersensitivity (Allergy) 12/2019 - 04/2002
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 11/2004
5	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2020 - 08/2010
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 12/2008
5	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 02/2009
4	Cicatrix (Scar) 01/2021 - 06/2013
4	Infections 01/2020 - 04/2012
4	Lymphoma (Lymphomas) 07/2015 - 11/2002
3	Pulmonary Arterial Hypertension 12/2019 - 01/2018
3	Fibrosis (Cirrhosis) 01/2019 - 08/2015
3	Muscular Diseases (Myopathy) 12/2016 - 06/2009
3	Atherosclerosis 01/2016 - 12/2005
3	Stomach Neoplasms (Stomach Cancer) 10/2015 - 01/2012
3	Diarrhea 01/2014 - 01/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011 - 08/2006
2	Confusion (Bewilderment) 05/2022 - 05/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2022 - 08/2021
2	Rheumatoid Arthritis 05/2022 - 08/2021
2	Obesity 01/2022 - 05/2014
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2021 - 01/2018
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 01/2018
2	Pulmonary Hypertension 12/2019 - 01/2018
2	Exanthema (Rash) 12/2019 - 08/2014
2	Hyperglycemia 03/2019 - 11/2018
2	Glucose Intolerance 03/2019 - 11/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 04/2017
2	Hypoxia (Hypoxemia) 01/2018 - 06/2008
2	Rhabdomyolysis 12/2017 - 01/2011
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2012
2	Inflammation (Inflammations) 01/2017 - 05/2005
2	Dementia (Dementias) 07/2014 - 03/2013
2	Epilepsy (Aura) 12/2013 - 02/2010

Drug/Important Bio-Agent (IBA)

41	Pharmaceutical PreparationsIBA 04/2022 - 01/2002
22	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2009
19	Irinotecan (Camptosar)FDA LinkGeneric 01/2014 - 01/2002
18	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2002
17	Selenoprotein PIBA 01/2022 - 11/2002
12	LipidsIBA 08/2020 - 06/2008
12	Gemcitabine FDA Link 01/2016 - 11/2004
11	HLA-B Antigens (HLA-B)IBA 01/2021 - 11/2008
7	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 02/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 08/2006
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2011
5	Oxidopamine (6 Hydroxydopamine)IBA 01/2018 - 03/2007
5	EnzymesIBA 10/2017 - 04/2002
5	Fluorouracil (Carac)FDA LinkGeneric 01/2012 - 11/2005
4	Allopurinol (Remid)FDA LinkGeneric 01/2021 - 11/2008
4	Phenytoin (Dilantin)FDA LinkGeneric 01/2021 - 11/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2007
4	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 02/2011 - 01/2002
3	SeleniumIBA 01/2022 - 01/2013
3	Insulin (Novolin)FDA Link 02/2020 - 01/2017
3	AntipyreticsIBA 01/2020 - 01/2011
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2019 - 07/2010
3	Phosphotransferases (Kinase)IBA 10/2018 - 07/2015
3	Protein Deglycase DJ-1IBA 03/2018 - 04/2014
3	NeurotoxinsIBA 01/2018 - 03/2007
3	AntibodiesIBA 01/2017 - 05/2014
3	AntigensIBA 01/2016 - 01/2012
3	Cysteine (L-Cysteine)FDA Link 07/2014 - 10/2010
3	AntioxidantsIBA 11/2012 - 04/2005
3	Cisplatin (Platino)FDA LinkGeneric 05/2010 - 04/2005
3	Cytidine DeaminaseIBA 01/2009 - 04/2005
3	PlatinumIBA 01/2009 - 01/2007
2	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2022 - 01/2011
2	Indicators and Reagents (Reagents)IBA 05/2022 - 05/2022
2	Immunosuppressive Agents (Immunosuppressants)IBA 08/2021 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021 - 01/2019
2	insulin receptor-related receptor (IRR)IBA 01/2021 - 01/2018
2	HLA-DRB1*04 antigenIBA 12/2020 - 12/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2011
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2018
2	Ether (Diethyl Ether)IBA 10/2019 - 01/2016
2	Prostaglandin D2IBA 10/2019 - 01/2019
2	Chemotactic FactorsIBA 03/2019 - 05/2014
2	Denosumab FDA Link 02/2019 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2015
2	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 09/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2016 - 01/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 02/2010
2	Protein Kinases (Protein Kinase)IBA 07/2015 - 05/2014
2	Caspase 8 (Caspase-8)IBA 07/2015 - 04/2014
2	Metformin (Glucophage)FDA LinkGeneric 06/2015 - 01/2014
2	HLA-A31 antigenIBA 01/2015 - 06/2013
2	Amyloid (Amyloid Fibrils)IBA 04/2014 - 05/2013

Therapy/Procedure

13	Therapeutics 12/2019 - 03/2005
7	Drug Therapy (Chemotherapy) 10/2015 - 04/2005
2	Combination Drug Therapy (Combination Chemotherapy) 12/2013 - 07/2007